Revenue
0 USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Annual consolidated revenue for 2025: about USD 0, using the latest reported figures. The previous period, 2024, was about USD 130.1K.
9487 USD
1475768095 shares
1,495.23% · 1.38 billion shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
0 USD
2025-06-01 – 2026-05-31
-462 thousand USD
2025-06-01 – 2026-05-31
-154 thousand USD
2025-06-01 – 2026-05-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-06-24.
Financial data available through: 2025-08-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 130,074
–
Current period
USD 0
–
0 − 130074 = -130074 USD
130074 USD · 2023-09-01 – 2024-08-31
Inspect prior input Prior source0 USD · 2024-09-01 – 2025-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 695,198
–
Current period
−USD 313,976
–
-313976 − -695198 = 381222 USD
-695198 USD · 2023-09-01 – 2024-08-31
Inspect prior input Prior source-313976 USD · 2024-09-01 – 2025-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 244,269
–
Current period
−USD 171,305
–
-171305 − -244269 = 72964 USD
-244269 USD · 2023-09-01 – 2024-08-31
Inspect prior input Prior source-171305 USD · 2024-09-01 – 2025-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2015-09-01 – 2016-08-31 | 112500 | 393177 Derived | -280677 | 26504 Derived | -307181 | Unavailable | Source
|
| 2017 2016-09-01 – 2017-08-31 | 5684 | 1859583 Derived | -1853899 | 79942 Derived | -1933841 | Unavailable | Source
|
| 2018 2017-09-01 – 2018-08-31 | 9601 | 3818329 Derived | -3808728 | -32111 Derived | -3776617 | Unavailable | Source
|
| 2019 2018-09-01 – 2019-08-31 | 9843 | 3313450 Derived | -3303607 | -4436577 Derived | 1132970 | Unavailable | Source
|
| 2020 2019-09-01 – 2020-08-31 | 7157 | 3050608 Derived | -3043451 | 4424013 Derived | -7467464 | Unavailable | Source
|
| 2021 2020-09-01 – 2021-08-31 | 0 | 2600177 Derived | -2600177 | 594270 Derived | -3194447 | Unavailable | Source
|
| 2022 2021-09-01 – 2022-08-31 | 29958 | 2983928 Derived | -2953970 | 769280 Derived | -3723250 | Unavailable | Source
|
| 2023 2022-09-01 – 2023-08-31 | 410165 | 1341545 Derived | -931380 | 2778854 Derived | -3710234 | Unavailable | Source
|
| 2024 2023-09-01 – 2024-08-31 | 130074 | 713213 Derived | -583139 | 112059 Derived | -695198 | Unavailable | Source
|
| 2025 2024-09-01 – 2025-08-31 | 0 | 271691 Derived | -271691 | 42285 Derived | -313976 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 112500 |
|
| 2017 | Revenue | 5684 |
|
| 2018 | Revenue | 9601 |
|
| 2019 | Revenue | 9843 |
|
| 2020 | Revenue | 7157 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 29958 |
|
| 2023 | Revenue | 410165 |
|
| 2024 | Revenue | 130074 |
|
| 2025 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | -94.9% |
|
| 2018 | Year over year | 68.9% |
|
| 2019 | Year over year | 2.5% |
|
| 2020 | Year over year | -27.3% |
|
| 2021 | Year over year | -100% |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 1,269.1% |
|
| 2024 | Year over year | -68.3% |
|
| 2025 | Year over year | -100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -249.5% |
|
| 2017 | Operating margin | -32,616.1% |
|
| 2018 | Operating margin | -39,670.1% |
|
| 2019 | Operating margin | -33,563% |
|
| 2020 | Operating margin | -42,524.1% |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | -9,860.4% |
|
| 2023 | Operating margin | -227.1% |
|
| 2024 | Operating margin | -448.3% |
|
| 2025 | Operating margin | Not reported |
|
| 2016 | Net margin | -273% |
|
| 2017 | Net margin | -34,022.5% |
|
| 2018 | Net margin | -39,335.7% |
|
| 2019 | Net margin | 11,510.4% |
|
| 2020 | Net margin | -104,337.9% |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | -12,428.2% |
|
| 2023 | Net margin | -904.6% |
|
| 2024 | Net margin | -534.5% |
|
| 2025 | Net margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -120103 |
|
| 2017 | Operating cash flow | -863567 |
|
| 2018 | Operating cash flow | -1974692 |
|
| 2019 | Operating cash flow | -3093782 |
|
| 2020 | Operating cash flow | -2774955 |
|
| 2021 | Operating cash flow | -2492913 |
|
| 2022 | Operating cash flow | -1679192 |
|
| 2023 | Operating cash flow | -112521 |
|
| 2024 | Operating cash flow | -244269 |
|
| 2025 | Operating cash flow | -171305 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 2,071% |
|
| 2017-08-31 | Liabilities / assets | Not reported |
|
| 2018-08-31 | Liabilities / assets | Not reported |
|
| 2019-08-31 | Liabilities / assets | Not reported |
|
| 2020-08-31 | Liabilities / assets | Not reported |
|
| 2021-08-31 | Liabilities / assets | Not reported |
|
| 2022-08-31 | Liabilities / assets | Not reported |
|
| 2023-08-31 | Liabilities / assets | Not reported |
|
| 2024-08-31 | Liabilities / assets | Not reported |
|
| 2025-08-31 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.04× |
|
| 2017 | Current assets / current liabilities | 5.03× |
|
| 2018 | Current assets / current liabilities | 3.01× |
|
| 2019 | Current assets / current liabilities | 9.81× |
|
| 2020 | Current assets / current liabilities | 2.04× |
|
| 2021 | Current assets / current liabilities | 1.25× |
|
| 2022 | Current assets / current liabilities | 0.08× |
|
| 2023 | Current assets / current liabilities | 0.09× |
|
| 2024 | Current assets / current liabilities | 0.01× |
|
| 2025 | Current assets / current liabilities | 0.01× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2015-09-01 – 2016-08-31 | −USD 307,181 Exact valueExact value: -307181 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 120,103 Exact valueExact value: -120103 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-09-01 – 2017-08-31 | −USD 1.93 million Exact valueExact value: -1933841 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 863,567 Exact valueExact value: -863567 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-09-01 – 2018-08-31 | −USD 3.78 million Exact valueExact value: -3776617 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.97 million Exact valueExact value: -1974692 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-09-01 – 2019-08-31 | USD 1.13 million Exact valueExact value: 1132970 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.09 million Exact valueExact value: -3093782 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-09-01 – 2020-08-31 | −USD 7.47 million Exact valueExact value: -7467464 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.77 million Exact valueExact value: -2774955 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-09-01 – 2021-08-31 | −USD 3.19 million Exact valueExact value: -3194447 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.49 million Exact valueExact value: -2492913 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-09-01 – 2022-08-31 | −USD 3.72 million Exact valueExact value: -3723250 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.68 million Exact valueExact value: -1679192 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-09-01 – 2023-08-31 | −USD 3.71 million Exact valueExact value: -3710234 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 112,521 Exact valueExact value: -112521 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-09-01 – 2024-08-31 | −USD 695,198 Exact valueExact value: -695198 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 244,269 Exact valueExact value: -244269 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-09-01 – 2025-08-31 | −USD 313,976 Exact valueExact value: -313976 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 171,305 Exact valueExact value: -171305 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
103 filings · 2,922 latest values · 2,927 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001343009, 1343009, CNBX, edgar:1343009
Also known as American Mining Corp, American Mining Corporation, CANNABICS PHARMACEUTICALS INC., CNBX PHARMACEUTICALS INC., CNBX Pharmaceuticals Inc., Cannabics Pharmaceuticals Inc., Thrust Energy Corp.